The workshop objective is to provide basic training on the role of the FDA and cancer patient advocates in oncology product development. This broad introduction to FDA regulatory aspects of oncology product development is most relevant to attendees with limited knowledge and experience in cancer product development and patient advocacy. Lunch time will feature time to network with FDA staff centered around specific cancers including: breast, ovarian, and gynecologic cancers, leukemia, lymphoma, melanoma, genitourinary cancers (prostate, kidney, bladder); gastrointestinal cancers (cholangiocarcinoma, neuroendocrine tumors, pancreatic); thoracic cancers (thyroid, lung, mesotheliomas); and central nervous system cancer.
There is no cost to attend and lunch is provided to registrants.
Location: FDA White Oak Campus Building 31 Great Room
10903 New Hampshire Avenue
Silver Spring, Maryland 20993